title: Rare incorporation of bone marrow-derived cells into kidney after folic acid-induced injury.
abstract: Results obtained in recent experiments suggest that bone marrow-derived cells (BMDCs) engraft into tissues and differentiate into various somatic cell types. However, it is unclear whether injury is required for the phenomenon to occur at appreciable frequencies. In this study we tested whether BMDCs engraft into kidneys and differentiate into renal cells in the absence or presence of toxic injury. Renal damage was induced by delivery of folic acid (FA) to bone marrow (BM)-recipient mice 1 or 9 months after bone marrow transplant, and kidneys were examined for donor-derived cells 2,4, or 8 weeks after injury. Donor-derived cells were abundant in the renal interstitium of injured kidneys and were detected in glomeruli of vehicle- and FA-treated mice. Most of these cells expressed the common leukocyte antigen CD45 and display morphological characteristics of white blood cells. No donor-derived renal tubule cells (RTCs) were detected in kidney sections of BM-recipient mice. However, in cell culture, a cluster of seven donor-derived cells of 4 x 10(6) RTCs examined (approximately 0.0002%) displayed morphological characteristics of RTCs. CD45+ cells of donor origin were also detected in glomeruli and glomerular outgrowths. Nested polymerase chain reaction analysis for the male-specific Sry gene in cultured RTCs and glomerular outgrowths confirmed the presence of donor-derived cells. These results suggest that BMDCs may incorporate into glomeruli as specialized glomerular mesangial cells; however, BMDCs rarely contribute to the repair of renal tubules in uninjured or FA-treated mouse kidneys.
authors.affiliation: Research Division, Nephros Therapeutics Inc., Ann Arbor, Michigan, USA. mszczypka@nephrostherapeutics.com
authors.forename: Mark S
authors.initials: MS
authors.lastname: Szczypka
authors.forename: Angela J
authors.initials: AJ
authors.lastname: Westover
authors.forename: Shawn G
authors.initials: SG
authors.lastname: Clouthier
authors.forename: James L M
authors.initials: JL
authors.lastname: Ferrara
authors.forename: H David
authors.initials: HD
authors.lastname: Humes
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D000818:Animals; D001854:Bone Marrow Cells / Q000502:physiology*; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D004195:Disease Models, Animal; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage / Q000633:toxicity*; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence / Q000379:methods; D066298:In Vitro Techniques; D007668:Kidney / Q000473:pathology* / Q000502:physiology / Q000648:ultrastructure; D007678:Kidney Glomerulus / Q000473:pathology / Q000502:physiology / Q000648:ultrastructure; D007684:Kidney Tubules / Q000473:pathology / Q000502:physiology / Q000648:ultrastructure; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D013045:Species Specificity
chemical_list: D005492:Folic Acid